Skip to main content
. 2022 Jun 10;30(8):2646–2663. doi: 10.1016/j.ymthe.2022.06.004

Table 1.

Summary of mouse studies that observed or investigated HCC formation after rAAV gene delivery

Publication AAV serotype Genome configuration Enhancer/promoter (∗promoters only) Transgene Route of delivery Dose Time of treatment Loci with integration(s) associated with HCC
Donsante 200142
Donsante 200746
2 SS CMV/CBA GUSB superficial temporal vein 1 × 1014 vg/kg neonatal Rian
Bell 200547 1,2,5,7,8,9, others SS Alb, CBA, SV40, TBG, Z12∗ A1AT, EGFP, Epo, FIX, LacZ, LDLR, TF1 portal vein
tail vein
3 × 109-1 × 1012 vg/mouse 6–8 weeks none
Bell 200648
Zhong 201349
2,7,8,9 SS AMPB/TBG Oct, LacZ portal vein 3 × 109-1 × 1012 vg/mouse 9–11 weeks Tax1bp1, Rian
Reiss 201150 1/2 SS CMV/CBA MOCS1 intrahepatic 1–3 × 109 vg/pup neonatal none
Embury 200851 2 SS CBA∗ (WPRE) mPah portal vein 3.7 × 109-7.3 × 1013 vg/mouse 10–14 weeks none
Li 201152 2 SS APOE/hAAT FIX portal vein 5 × 1012-1 × 1014 vg/kg 4 weeks none
Wang 201253 2 SS CMV/CBA Homology Arms to Rian temporal vein 3 × 109 vg/pup neonatal Rian
Rosas 201254 Rh74 SC CMV, CBA∗ GFP, null tail vein 5 × 1010 vg/mouse 8–12 weeks Hras1, Sos1, Fgf3
Kao 201355 8 SS APOE/hAAT FIX-WT, FIX-Triple, FIX-Padua tail vein 1.6 × 1012-2 × 1010 vg/mouse adult none
Chandler 201556 2,8,9 SS AMPB/TBG CMV/CBA
APOE/hAAT
hMUT, mMut, GFP intrahepatic 7 × 1012-1 × 1014 vg/kg neonatal Rian
Walia 201557 9 SS CMV/CMV HexB, LacZ superficial temporal vein 2.5 × 1014 vg/kg neonatal Rian
Kang 201958 9 SS TBG G6PC, ZFN tail vein 4.8 × 1012-1.3 × 1013 vg/kg adult Rian
Dalwadi 202159 DJ SS CMV/CAG Homology Arms to Rian, tdTomato superficial temporal vein 3 × 1010 vg/pup
8 × 1011 vg/adult
neonatal
adults
Rian
Li 202160 9 SS CMV/CBA GALC intracranial or intrathecal 2.7 × 1010 vg/pup neonatal Rian, FoxP1, Tusc3, Magi1, Kcnh1, Akap13

HCC, hepatic carcinoma; rAAV, recombinant adeno-associated virus; SS, single stranded; SC, self-complementary; CMV, cytomegalovirus; CBA, chicken beta-actin; Alb, albumin; TBG, thyroxin binding globulin; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; TBG, thyroxin binding globulin; APOE, apolipoprotein E; hAAT, human alpha-1 antitrypsin; CAG, cytomegalovirus enhancer/chicken beta-actin promoter.

Adapted from Chandler, 2017.25